Some antibodies are restricted to specific cancer types (e.g., EGFR‐, HER2‐expressing tumors) or could suffer from low selectivity because their target cell‐surface markers are also expressed by other cells (e.g., VCAM‐1, ICAM‐1) [60]. This evidence concerns the gene EGFR and cancer.